Dove Medical Press
|Country of origin||United Kingdom|
|Headquarters location||Macclesfield, Cheshire, England|
|Key people||Tim Hill, Publisher|
|Nonfiction topics||Science and Medicine|
|Number of employees||50|
Dove Medical Press is an academic publisher of open access peer-reviewed scientific and medical journals, with offices in Manchester, London (United Kingdom), Princeton, New Jersey (United States), and Auckland (New Zealand).
As an open access publisher, Dove charges a publication fee to authors or their institutions or funders. This charge allows Dove to recover its editorial and production costs and to create a pool of funds that can be used to provide fee waivers for authors from lesser developed countries. Articles published are available via an interface following the Open Archives Initiative Protocol for Metadata Harvesting, a set of uniform standards promulgated by the Open Archives Initiative allowing metadata on archive holdings.
Dove is a member of the Association of Learned and Professional Society Publishers, the Committee on Publication Ethics, and the Open Archives Initiative. As of April 2013[update], it publishes 131 journals.
As of 11 April 2013[update], 42 of the 131 journals were indexed in PubMed, while 30 of the 131 journals had fewer than 10 articles. In 2012, the company was included on Beall's list of predatory open access publishers, but was later removed.
Dove Medical Press is a member and sponsor for multiple professional organizations. They also support scientific dissemination by sponsoring events such as the annual International Translational Nanomedicine conference (ITNano) started in 2013,  and awards such as the Distinguished Career, and the Young Scholar Awards, presented by one of their journals, the International Journal of Nanomedicine (IJN).
In 2013, the Dove Medical Press journal Drug Design, Development and Therapy accepted a false and intentionally flawed paper created and submitted by an investigative journalist for Science as part of a "sting" to test the effectiveness of the peer-review processes of open access journals (Who's Afraid of Peer Review?). The Open Access Scholarly Publishers Association terminated Dove's membership as a result of the incident. After satisfying The Open Access Scholarly Publishers Association Membership Committee that new editorial and peer review procedures were in place to address the concerns raised during its investigation, Dove Medical Press was reinstated as a full member of Open Access Scholarly Publishers Association in September 2015.
All articles, including meta-data and supplementary files, are published under the Creative Commons Attribution license.
- "Hiring Guru: Tim Hill, Breaking Bad Templates". The Huffington Post.
- Dove Press. "Dove Medical Press - About Us - Dove Press". Homepage.
- "Publication Processing Fees". Retrieved 1 September 2015.
- "Open Archives Initiative". Retrieved 13 May 2015.
- "Registration Record". Dove Medical Press.
- Dove Press. "Browse Journals". Homepage.
- "Dove Medical Press publishes 10,000 academic papers" (Press release). Scoop Media. 27 September 2012. Retrieved 23 January 2014.
- "The Open Access Interviews: Dove Medical Press". 5 November 2008. Retrieved 13 May 2015.
- Beall, Jeffrey (2012). "Beall's List of Predatory, Open-Access Publishers" (PDF). University of Colorado Denver website. Retrieved 29 January 2014.
- Kolata, Gina (8 April 2013). "Scientific Articles Accepted (Personal Checks, Too)". The New York Times. Retrieved 31 March 2014.
- "Professional Memberships". 23 July 2014. Retrieved 1 September 2015.
- "ITNano2015". Retrieved 1 September 2015.
- "International Journal of Nanomedicine". Retrieved 1 September 2015.
- "carboNZero Certified Organisations".
- Malakoff, David (11 November 2013). "Open-Access Group Sanctions Three Publishers After Science 'Sting'". Science Insider. Retrieved 31 March 2014.
- Redhead, Claire (23 September 2015). "Dove Medical Press reinstated as OASPA Members". Retrieved 29 September 2015.